Merck Announces Neoclease as Winner of 2025 North American Advance Biotech Grant

Published on 08/07/2025 at 17:58 | businesswire.com

Merck, a leading science and technology company, today announced Neoclease as the winner of the 2025 North American Advance Biotech Grant. The Boston-based biotech startup develops AI-designed gene editing therapies for Parkinson’s disease.

to register online, change your selection or discontinue this service.